{"nct_id":"NCT00436007","title":"Safety and Immunogenicity Study of GSK Biologicals' Malaria Vaccine 257049, When Incorporated Into an EPI Regimen","status":"COMPLETED","status_verified_date":"2017-04","start_date":"2007-04-30","start_date_type":null,"primary_completion_date":"2008-09-15","primary_completion_date_type":"ACTUAL","completion_date":"2009-10-07","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}